HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olli Carpén Selected Research

Nervous System Neoplasms (Neoplasms, Nervous System)

7/2007The tumor suppressor merlin interacts with microtubules and modulates Schwann cell microtubule cytoskeleton.
4/2005Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system.
4/2004Cyclic AMP-dependent protein kinase phosphorylates merlin at serine 518 independently of p21-activated kinase and promotes merlin-ezrin heterodimerization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olli Carpén Research Topics

Disease

46Neoplasms (Cancer)
01/2022 - 09/2002
16Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 02/2013
6Carcinoma (Carcinomatosis)
01/2022 - 08/2003
6Melanoma (Melanoma, Malignant)
03/2021 - 08/2003
5Colorectal Neoplasms (Colorectal Cancer)
11/2019 - 12/2008
5Neurofibromatosis 2 (Neurofibromatosis Type II)
09/2012 - 10/2003
4Neoplasm Metastasis (Metastasis)
12/2018 - 12/2008
4Adenocarcinoma
01/2018 - 10/2009
3Ovarian Epithelial Carcinoma
01/2020 - 12/2014
3Nervous System Neoplasms (Neoplasms, Nervous System)
07/2007 - 04/2004
2Disease Progression
11/2021 - 01/2021
2Stomach Neoplasms (Stomach Cancer)
11/2021 - 01/2016
2Rectal Neoplasms (Rectal Cancer)
06/2018 - 03/2011
2Triple Negative Breast Neoplasms
01/2018 - 08/2011
2Breast Neoplasms (Breast Cancer)
01/2018 - 08/2013
2Endometrial Neoplasms (Endometrial Cancer)
06/2015 - 10/2009
2Myofibrillar Myopathy
01/2009 - 04/2005
2Muscular Diseases (Myopathy)
01/2008 - 01/2003
2Glioma (Gliomas)
07/2007 - 02/2005
2Carotid Artery Diseases
01/2007 - 01/2005
2Infections
03/2006 - 12/2002
2Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
04/2005 - 01/2003
1Chronic Pain
01/2022
1Bronchopulmonary Dysplasia
01/2022
1Fatigue
12/2021
1Cardiovascular Diseases (Cardiovascular Disease)
12/2021
1COVID-19
12/2021
1Mental Fatigue
12/2021
1Genetic Predisposition to Disease (Genetic Predisposition)
11/2021
1Glioblastoma (Glioblastoma Multiforme)
07/2020
1Granulosa Cell Tumor
04/2020
1Peripheral Nervous System Diseases (PNS Diseases)
01/2020
1Ascites
01/2020
1Intellectual Disability (Idiocy)
01/2020
1Leiomyosarcoma
03/2017
1Sarcoma (Soft Tissue Sarcoma)
03/2017
1Adenosarcoma
03/2017
1Endometrial Stromal Sarcoma
03/2017
1Smooth Muscle Tumor
03/2017

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2003
10RNA (Ribonucleic Acid)IBA
01/2022 - 12/2002
9ezrinIBA
01/2019 - 08/2003
8Biomarkers (Surrogate Marker)IBA
12/2020 - 06/2015
8Neurofibromin 2 (Merlin)IBA
09/2012 - 09/2003
7ForminsIBA
11/2021 - 01/2013
6AntigensIBA
04/2021 - 07/2009
5PlatinumIBA
01/2021 - 08/2015
3Pharmaceutical PreparationsIBA
01/2022 - 01/2017
3Biological ProductsIBA
01/2017 - 12/2008
3moesinIBA
04/2005 - 10/2003
3radixinIBA
04/2005 - 10/2003
2Apolipoproteins E (ApoE)IBA
12/2021 - 10/2009
2ApolipoproteinsIBA
12/2021 - 10/2009
2Drug CombinationsIBA
11/2021 - 01/2018
2LipidsIBA
04/2021 - 01/2005
2DNA (Deoxyribonucleic Acid)IBA
08/2020 - 12/2008
2ParaffinIBA
08/2020 - 01/2017
2Small Interfering RNA (siRNA)IBA
07/2020 - 01/2017
2Indicators and Reagents (Reagents)IBA
01/2020 - 01/2020
2AntibodiesIBA
12/2018 - 01/2016
2EnzymesIBA
01/2018 - 07/2009
2Progesterone Receptors (Progesterone Receptor)IBA
09/2013 - 08/2013
2FilaminsIBA
01/2008 - 01/2003
2Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
07/2007 - 10/2003
1Opioid Analgesics (Opioids)IBA
01/2022
1Analgesics (Analgesic Drugs)IBA
01/2022
1Methadone (Dolophine)FDA LinkGeneric
01/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022
1mu Opioid Receptors (mu Opioid Receptor)IBA
01/2022
1Apolipoprotein E4IBA
12/2021
1Oncogene Proteins (Oncogene Protein)IBA
11/2021
1Therapeutic UsesIBA
11/2021
1LigandsIBA
01/2021
1ErythropoietinFDA Link
01/2021
1Eph Family Receptors (Eph Receptors)IBA
01/2021
1EphrinsIBA
01/2021
1Ephrin-A5 (AL-1)IBA
01/2021
1Formaldehyde (Formol)FDA Link
08/2020
1Aromatase (CYP19)IBA
04/2020
1Hormones (Hormone)IBA
04/2020
1Estradiol (Delestrogen)FDA LinkGeneric
04/2020
1Messenger RNA (mRNA)IBA
01/2020
1Aurora KinasesIBA
01/2020
1Tumor Biomarkers (Tumor Markers)IBA
01/2019
1Circulating Tumor DNAIBA
01/2019
1ErbB Receptors (EGF Receptor)IBA
12/2018
1SilverIBA
12/2018
1ProstaglandinsIBA
01/2018
1Oxidoreductases (Dehydrogenase)IBA
01/2018
1Arachidonic Acid (Vitamin F)IBA
01/2018
1Fatty Acids (Saturated Fatty Acids)IBA
01/2018
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2018
1Ribosomal Proteins (Ribosomal Protein)IBA
03/2017

Therapy/Procedure

12Therapeutics
11/2021 - 01/2007
8Drug Therapy (Chemotherapy)
01/2022 - 08/2013
4Neoadjuvant Therapy
01/2020 - 02/2013
3Adjuvant Chemotherapy
11/2019 - 08/2013
2Radiotherapy
06/2018 - 03/2011
1Critical Care (Surgical Intensive Care)
12/2021
1Aftercare (After-Treatment)
01/2019